Exchange: NASDAQ·Updated 03:59 PM EDT
CARA logo

CARACara Therapeutics Inc

$3.83
$0.13
(3.27%)
Today
Closed $3.85
$0.02
(0.52%)
After Hours
Reported EarningsMay 8
Mkt Cap$37.34M
Vol653.00

About

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10

Frequently Asked Questions

What is Market Cap of Cara Therapeutics Inc?
What is the 52-week high for Cara Therapeutics Inc?
What is the 52-week low for Cara Therapeutics Inc?
What is Cara Therapeutics Inc stock price today?
What was Cara Therapeutics Inc stock price yesterday?
What is the PE ratio of Cara Therapeutics Inc?
What is the Price-to-Book ratio of Cara Therapeutics Inc?
What is the 50-day moving average of Cara Therapeutics Inc?
How many employees does Cara Therapeutics Inc have?

Advertisement|Remove ads.